The Prof G Pod with Scott Galloway Prof G Markets: Ozempic’s Market Impacts and Surging Bond Yields — with Downtown Josh Brown
47 snips
Oct 9, 2023 Downtown Josh Brown, CEO of Ritholtz Wealth, joins to unravel the recent surge in bond yields and its implications for investors. They discuss how Ozempic’s rising popularity could disrupt markets, particularly the fast food and alcohol industries, reshaping consumer behaviors. The duo also delves into investment strategies focused on struggling companies and critiques AI company valuations amidst evolving market dynamics. With humor and insight, they tackle the complexities of navigating today’s financial landscape.
AI Snips
Chapters
Transcript
Episode notes
Ozempic's Economic Impact
- Ozempic's rise is a major economic story, potentially exceeding AI's impact.
- It could drastically reduce obesity's $1.7 trillion annual cost, boosting GDP.
Ozempic's Impact on Food Stocks
- Food company stock prices correlate with obesity rates in America.
- As obesity rates decline with Ozempic, these stocks might suffer.
Shorting Ozempic-Affected Companies
- Consider shorting companies negatively impacted by Ozempic, but remember this is not financial advice.
- These include fast food, retailers like Walmart, and even some hospital complexes.